Advanced in Primitive Neuroectodermal Tumor (PNET)

Dr. Inna Shmerlin

Oncology
Baylor Scott & White Health
Texas Oncology, P.A.
1441 N. Beckley Avenue, Suite 101, 
Dallas, TX 
Offers Telehealth
25 Years of Experience

Advanced in Primitive Neuroectodermal Tumor (PNET)
Baylor Scott & White Health
Texas Oncology, P.A.
1441 N. Beckley Avenue, Suite 101, 
Dallas, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Inna Shmerlin is an Oncologist in Dallas, Texas. Dr. Shmerlin has been practicing medicine for over 25 years and is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET).

Her clinical research consists of participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Texas Medical Branch At Galveston, 2001.0
Residency
Internal Medicine, Baylor University Hospital
Specialties
Oncology
Licenses
Internal Medicine in TX
Fellowships
Medical Oncology, Baylor University Hospital
Hospital Affiliations
Methodist Dallas Medical Center
Methodist Charlton Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Scott and White Health
  • HMO
  • POS
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Texas Oncology, P.A.
1441 N. Beckley Avenue, Suite 101, Dallas, TX 75203
Call: 972-449-0540

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

EMBER-3: A Phase 3, Randomized, Open-Label Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Patients With Estrogen Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With Endocrine Therapy
EMBER-3: A Phase 3, Randomized, Open-Label Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Patients With Estrogen Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With Endocrine Therapy
Enrollment Status: Active_not_recruiting
Publish Date: July 11, 2025
Intervention Type: Drug
Study Drugs: Imlunestrant, Exemestane, Fulvestrant, Abemaciclib
Study Phase: Phase 3
Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs Placebo in Combination With Capecitabine and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma
Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs Placebo in Combination With Capecitabine and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma
Enrollment Status: Completed
Publish Date: August 14, 2023
Intervention Type: Drug
Study Drugs: tucatinib, capecitabine, trastuzumab
Study Phase: Phase 2
A Randomized Phase 2 Trial of AM0010 in Combination With Nivolumab vs. Nivolumab Alone as Second-Line Therapy in Subjects With Stage IV / Metastatic Wild Type Non-Small Cell Lung Cancer and Low Tumor Expression of PD-L1
A Randomized Phase 2 Trial of AM0010 in Combination With Nivolumab vs. Nivolumab Alone as Second-Line Therapy in Subjects With Stage IV / Metastatic Wild Type Non-Small Cell Lung Cancer and Low Tumor Expression of PD-L1
Enrollment Status: Terminated
Publish Date: September 11, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2
View 2 Less Clinical Trials
Similar Doctors
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Michael Youssef
Neurology | Oncology
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Michael Youssef
Neurology | Oncology

University Of Texas Southwestern Medical Center At Dallas

5303 Harry Hines Blvd, Suite 4, 
Dallas, TX 
 (3.7 miles away)
214-645-0624
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Michael Youssef is a Neurologist and an Oncologist in Dallas, Texas. Dr. Youssef is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, and Oligodendroglioma.

Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Elizabeth A. Maher
Hematology Oncology | Hematology | Oncology
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Elizabeth A. Maher
Hematology Oncology | Hematology | Oncology

University Of Texas Southwestern Medical Center At Dallas

400 W Magnolia Ave, 
Fort Worth, TX 
 (29.3 miles away)
817-288-9800
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Elizabeth Maher is a Hematologist Oncology specialist and a Hematologist in Fort Worth, Texas. Dr. Maher is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Embryonal Tumor with Multilayered Rosettes, Gliosarcoma, Astrocytoma, and Atypical Teratoid Rhabdoid Tumor (ATRT).

Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Randall Hughes
Hematology | Oncology
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Randall Hughes
Hematology | Oncology

University Of Texas Southwestern Medical Center At Dallas

5323 Harry Hines Blvd, 
Dallas, TX 
 (3.7 miles away)
216-648-0600
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Randall Hughes is a Hematologist and an Oncologist in Dallas, Texas. Dr. Hughes is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Endoscopy.

VIEW MORE PRIMITIVE NEUROECTODERMAL TUMOR (PNET) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shmerlin's expertise for a condition
ConditionClose
    • Distinguished
    • Breast Cancer
      Dr. Shmerlin is
      Distinguished
      . Learn about Breast Cancer.
      See more Breast Cancer experts
    • Paget Disease of the Breast
      Dr. Shmerlin is
      Distinguished
      . Learn about Paget Disease of the Breast.
      See more Paget Disease of the Breast experts
    • Advanced
    • Atypical Teratoid Rhabdoid Tumor (ATRT)
      Dr. Shmerlin is
      Advanced
      . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
      See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
    • Brain Tumor
      Dr. Shmerlin is
      Advanced
      . Learn about Brain Tumor.
      See more Brain Tumor experts
    • Embryonal Tumor with Multilayered Rosettes
      Dr. Shmerlin is
      Advanced
      . Learn about Embryonal Tumor with Multilayered Rosettes.
      See more Embryonal Tumor with Multilayered Rosettes experts
    • Ependymoma
      Dr. Shmerlin is
      Advanced
      . Learn about Ependymoma.
      See more Ependymoma experts
    • Glioblastoma
      Dr. Shmerlin is
      Advanced
      . Learn about Glioblastoma.
      See more Glioblastoma experts
    • Neuroepithelioma
      Dr. Shmerlin is
      Advanced
      . Learn about Neuroepithelioma.
      See more Neuroepithelioma experts
    View All 10 Advanced Conditions
    • Experienced
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Shmerlin is
      Experienced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Anal Cancer
      Dr. Shmerlin is
      Experienced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • Anaplastic Large Cell Lymphoma
      Dr. Shmerlin is
      Experienced
      . Learn about Anaplastic Large Cell Lymphoma.
      See more Anaplastic Large Cell Lymphoma experts
    • Astrocytoma
      Dr. Shmerlin is
      Experienced
      . Learn about Astrocytoma.
      See more Astrocytoma experts
    • Cervical Cancer
      Dr. Shmerlin is
      Experienced
      . Learn about Cervical Cancer.
      See more Cervical Cancer experts
    • Cholangiocarcinoma (Bile Duct Cancer)
      Dr. Shmerlin is
      Experienced
      . Learn about Cholangiocarcinoma (Bile Duct Cancer).
      See more Cholangiocarcinoma (Bile Duct Cancer) experts
    View All 53 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Close
        0 / 1000

        Please provide us with the below insurance information:

                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.